Europe / SWEDEN
Company Overview
AcuCort AB engages in the development, market, and sale of Dexa oral dissolvable films. Its product is primarily for acute allergic reaction, croup, and chemotherapy-induced nausea, and vomiting. The company was founded on November 15, 2006 and is headquartered in Lund, Sweden.
AcuCort AB engages in the development, market, and sale of Dexa oral dissolvable films. Its product is primarily for acute allergic reaction, croup, and chemotherapy-induced nausea, and vomiting. The company was founded on November 15, 2006 and is headquartered in Lund, Sweden.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Pharmaceutical Preparations |
| Country | SWEDEN |
| Employees | 5 |
| Reporting Unit | Millions |
| Primary Exchange | Unknown exchange |
| Instrument Type | Equity |
| Website | http://acucort.se |
| Wright ID | C752J9J8R |
Key Metrics
| Current price | $0.42 |
| Market cap | $98.5 M |
| P/E ratio | n/a |
| 52-week perf. | -29.8% |
| Common shares | 234.4 M |
| Share type | Aktie |
| Quality rating | LBL0 |
| Dividend yield | 0.00% |
Recent stock performance
| 1 Week | +2.9% |
| 4 Week | -13.8% |
| 13 Week | -35.2% |
Officers
n/a
Address
Scheeletorget 1
LUND
SWEDEN
223 81
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.